Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01934894
Title Cabazitaxel Plus Lapatinib as Therapy for HER2-Positive Metastatic Breast Cancer Patients With Intracranial Metastases
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors SCRI Development Innovations, LLC
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Florida Cancer Specialists - South Fort Myers Florida 33916 United States Details
Florida Cancer Specialists-North Saint Petersburg Florida 33705 United States Details
Oncology Hematology Care Inc. Cincinnati Ohio 45242 United States Details
Tennessee Oncology Nashville Tennessee 37203 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field